Nsengi Ntamabyaliro, MD, MSc; UPC-PV, University of Kinshasa

FHI Clinical has worked with Nsengi Ntamabyaliro, MD, MSc, from the Unit of Clinical Pharmacology and Pharmacovigilance (UPC-PV), University of Kinshasa, in Kinshasa, Democratic Republic of the Congo (DRC), on Phase 3 and 4 trials since 2007, at which time there was a focus on research capacity development in the DRC.

Continue ReadingNsengi Ntamabyaliro, MD, MSc; UPC-PV, University of Kinshasa

Meet Andy Fleming, Senior Account Development Manager, Client Solutions, Based in the United States

  • Post author:
  • Post category:Team

Andy brings his years of sales experience in the clinical research industry to his role in the FHI Clinical Client Solutions team. When he's not at work, he enjoys cycling with his wife, cooking, coffee and more.

Continue ReadingMeet Andy Fleming, Senior Account Development Manager, Client Solutions, Based in the United States

Equitable Access to Research Is Intrinsic to Health Equity 

  • Post author:
  • Post category:Blog

Equity in research plays a vital role in equity in health and health care, starting with clinical trials and carrying through post-marketing access to new vaccines and treatments. Read this blog post for a deeper dive into where the industry stands with equitable access and how it contributes to the success of a trial.

Continue ReadingEquitable Access to Research Is Intrinsic to Health Equity